Cargando…
EU Clinical Trials Regulation 2014: Fetter or facilitator?
European Union (EU) Clinical Trials Regulation 536/2014, expected to come into force in 2019, provides for a streamlined single EU application for cross-border clinical trials and enhanced transparency of results. The status of the Regulation in post-Brexit UK is uncertain. Matters of regulatory ali...
Autor principal: | Cave, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290553/ https://www.ncbi.nlm.nih.gov/pubmed/30595625 http://dx.doi.org/10.1177/0968533218799535 |
Ejemplares similares
-
A Fettered Mind
por: Witmer, Lightner
Publicado: (1917) -
The Fetters of Organization (Minority Rule)
Publicado: (1906) -
Rethinking the role of Research Ethics Committees in the light of Regulation (EU) No 536/2014 on clinical trials and the COVID‐19 pandemic
por: Tusino, Silvia, et al.
Publicado: (2021) -
Clinical Trial Data Transparency in the EU: Is the New Clinical Trials Regulation a Game-Changer?
por: Zemła-Pacud, Żaneta, et al.
Publicado: (2023) -
Redundant trials can be prevented, if the EU clinical trial regulation is applied duly
por: Kim, Daria, et al.
Publicado: (2020)